AAAAAA

   
Results: 1-3 |
Results: 3
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/, Journal of acquired immune deficiency syndromes and human retrovirology, 11(3), 1996, pp. 315-315
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 279-288
A PHASE-I CLINICAL-TRIAL TO EVALUATE THE SAFETY AND BIOLOGICAL-ACTIVITY OF HIV-IT (TAF) (HIV-1(IIIB)ENV-TRANSDUCED, AUTOLOGOUS FIBROBLASTS)IN ASYMPTOMATIC HIV-1-INFECTED SUBJECTS
Authors: GALPIN JE CASCIATO DA RICHARDS SB
Citation: Je. Galpin et al., A PHASE-I CLINICAL-TRIAL TO EVALUATE THE SAFETY AND BIOLOGICAL-ACTIVITY OF HIV-IT (TAF) (HIV-1(IIIB)ENV-TRANSDUCED, AUTOLOGOUS FIBROBLASTS)IN ASYMPTOMATIC HIV-1-INFECTED SUBJECTS, Human gene therapy, 5(8), 1994, pp. 997-1017
Risultati: 1-3 |